Nextleaf Solutions Ltd. Canada’s most innovative cannabis extractor, is pleased to announce that it has completed the previously announced acquisition of all of the issued and outstanding shares of Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs“), a Company that holds Health Canada standard processing and research licenses under the Cannabis Act (the “Acquisition“).
The closing of the Acquisition represents an important milestone for the Company, allowing OILS to continue the commercialization of its intellectual property (“IP“) portfolio through the production and wholesale of THC and CBD based oils and concentrates by Labs. The Company owns a portfolio of 40 issued patents and over 60 pending patents for the extraction, purification, and formulation of cannabinoids.
As consideration for the Acquisition, Nextleaf issued 1,000,000 common shares (the “Shares“) to the sole shareholder of Labs (the “Seller“) at a deemed price of $0.385 per share for aggregate consideration of $385,000. 250,000 Shares were released to the Seller on closing, with the remaining 750,000 Shares subject to an escrow agreement providing for the release of such Shares in three equal tranches every six months. All Shares issued are subject to a four month and one day hold period in accordance with Canadian securities laws.
For further information, please contact:
604-283-2301 (ext. 219)
On behalf of the Board of Directors of OILS,
Paul Pedersen, CEO
Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed, approved or disapproved the contents of this press release.